EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSNGAG00000003866
Gene Symbol: RARG
3 Cross references
446 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSNGAG00000020257
Gene Symbol: RXRA
3 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSNGAG00000014876
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSNGAG00000017760
Gene Symbol: RXRG
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSNGAG00000021389
Gene Symbol: RPL10A
3 Cross references
167 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSNGAG00000018109
Gene Symbol: RPL11
3 Cross references
135 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSNGAG00000021984
Gene Symbol: RPL13A
3 Cross references
313 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSNGAG00000010949
Gene Symbol: RPL14
3 Cross references
252 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSNGAG00000011612
Gene Symbol: RPL15
2 Cross references
110 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSNGAG00000009552
Gene Symbol: RPL18
3 Cross references
236 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSNGAG00000024087
Gene Symbol: RPL18A
3 Cross references
161 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSNGAG00000020684
Gene Symbol: RPL19
3 Cross references
239 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).